Southport Reporter ® Online Newspaper for Merseyside
Southport and Mersey Reporter- Your online only weekly Newspaper.
Your Online Newspaper for the Merseyside Area.

Click on to see our Twitter Feed.  Click on to see our Facebook Page.  Click on to follow our LinkedIn Profile.  This website is licence to carry news from Vamphire.com and UK Press Photography. 


Latest Edition Archive Shop Order Photos Help Group Hub

 

Click here to access your advert administration page.
Advertisers  Admin
 

Click here to get seen in our 'Business Index' and also to get on our banner system oppersite and pay online today via 'Pay Pal'...!
Advert Options

 
Updated news stories weekly.  Published online only. en Southport and Mersey Reporter

Your online newspaper.  Your words.

Publication date:- 2016-12-30

user-generated Headlines and reports on this page = 2 news items.    Page - 1.

Scientists at The Clatterbridge Cancer Centre use modified cold sore virus in cancer research

PATIENTS at The Clatterbridge Cancer Centre NHS Foundation Trust are benefitting from ground breaking research that has modified the cold sore virus to treat skin cancer.

The Hospital, in Merseyside, is 1 of the top recruiters for an international trial to use the genetically modified version of herpes on melanoma patients.

The therapy could lengthen the life expectancy of some sufferers.

Called T-VEC, it is injected directly into the tumours and releases substances to help fight cancer. Crucially it is not harmful to normal cells.

T-VEC has been granted interim funding from the Cancer Drugs Fund under strict guidelines about who will and won't be able to receive the treatment.

Significantly, it is only to treat melanoma that has not spread to bone, brain, lung or other internal organs. It must also be shown that other drugs are not suitable for that particular patient.

The researchers at The Clatterbridge Cancer Centre, in Wirral, are hoping to learn more about exactly the type of patients who will benefit most from the drug.  Dr Joseph Sacco, Consultant in Medical Oncology at The Clatterbridge Cancer Centre, and local investigator for the trial, said:- "This stage of the trial has been about understanding more about how treatment works in patients, both locally in injected lesions, and through the stimulation of the immune system. Ultimately we hope that the research will help us identify which patients are most likely to benefit, thus helping us choose which patients to offer T-VEC to, minimising side effects while maximising treatment. We want to understand better exactly where to use it. T-VEC is a good new option for people with melanoma as it has low toxicity. It is exciting to see it changing outcomes, heralding a new class of drugs becoming available to use as a single agent, or with other treatments."

The findings from The Clatterbridge Cancer Centre  will now be examined, along with those from a number of centres around the world.  

The results will allow consultants to decide how and when to treat patients with T-VEC. It is expected the treatment will become available to suitable patients under the strict guidelines in 2017.

News Report Page Quick Flick.

Click on here to go back to this week's home page! News Report Page Quick Flick
Click on this section to see last weeks edition of Southport and Mersey Reporter!
 

Sign up today for our daily email news service!

Sign up to our Daily Email News Service by clicking here now...

Did you know we where the UK's 1st online only newspaper and we still are?  Here at Southport and Mersey Reporter  we are still at  leading the way for local news.

All email addresses and information is held under the UK's Data Protection Act.

 

 

 

Contact us:-
(+44)  08443 244 195
Calls will cost 7p per minute, plus your telephone company's access charge.
Calls to this number may be recorded for security, broadcast, training and record keeping.

RSS  Weekly Headline Update Notices

  
News24@SouthportReporter.com
4a Post Office Ave, Southport, Merseyside, PR9 0US, UK
 
This online newspaper and information service is regulated by IMPRESS, the independent monitor for the UK's press.

This online newspaper and information service is regulated by IMPRESS the independent monitor for the UK's press.

How to make a complaint

This is our process:-  Complaints Policy  -  Complaints Procedure  -  Whistle Blowing Policy

 

See the view live webcamera images of the road outside our studio/newsroom in the hart of Southport.

Our live Southport Webcam image above.
To see it live, please click on image.

Event Notices

More events that are taking place on Merseyside can be found on our Event Listings Calendar.

Find out whats on in and around Merseyside! Click on here to see our event calendar.
Are you going to this event?  If you are please let us know what you thought of it!

These are our other websites within the Southport & Mersey Reporter Network.

Mersey Reporter - OUR HUB WEBSITE. Liverpool Reporter - Our online music station. Southport TV - Our online video archive.
Mersey Reporter Formby Reporter Liverpool Reporter Southport TV
 

 

Tracking & Cookie Usage Policy - Terms & Conditions

© - Southport Reporter® is the Registered Trade Mark of Patrick Trollope

..